Table of Contents Executive Summary 1 Industry Overview of Facial Erythema Therapies 1.1 Definition of Facial Erythema Therapies 1.2 Facial Erythema Therapies Segment by Type 1.2.1 Global Facial Erythema Therapies Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Rx 1.2.3 OTC 1.3 Facial Erythema Therapies Segment by Applications 1.3.1 Global Facial Erythema Therapies Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Global Facial Erythema Therapies Overall Market 1.4.1 Global Facial Erythema Therapies Revenue (2014-2025) 1.4.2 Global Facial Erythema Therapies Production (2014-2025) 1.4.3 North America Facial Erythema Therapies Status and Prospect (2014-2025) 1.4.4 Europe Facial Erythema Therapies Status and Prospect (2014-2025) 1.4.5 China Facial Erythema Therapies Status and Prospect (2014-2025) 1.4.6 Japan Facial Erythema Therapies Status and Prospect (2014-2025) 1.4.7 Southeast Asia Facial Erythema Therapies Status and Prospect (2014-2025) 1.4.8 India Facial Erythema Therapies Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Facial Erythema Therapies 2.3 Manufacturing Process Analysis of Facial Erythema Therapies 2.4 Industry Chain Structure of Facial Erythema Therapies 3 Development and Manufacturing Plants Analysis of Facial Erythema Therapies 3.1 Capacity and Commercial Production Date 3.2 Global Facial Erythema Therapies Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Facial Erythema Therapies 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Facial Erythema Therapies Production and Capacity Analysis 4.2 Facial Erythema Therapies Revenue Analysis 4.3 Facial Erythema Therapies Price Analysis 4.4 Market Concentration Degree 5 Facial Erythema Therapies Regional Market Analysis 5.1 Facial Erythema Therapies Production by Regions 5.1.1 Global Facial Erythema Therapies Production by Regions 5.1.2 Global Facial Erythema Therapies Revenue by Regions 5.2 Facial Erythema Therapies Consumption by Regions 5.3 North America Facial Erythema Therapies Market Analysis 5.3.1 North America Facial Erythema Therapies Production 5.3.2 North America Facial Erythema Therapies Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Facial Erythema Therapies Import and Export 5.4 Europe Facial Erythema Therapies Market Analysis 5.4.1 Europe Facial Erythema Therapies Production 5.4.2 Europe Facial Erythema Therapies Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Facial Erythema Therapies Import and Export 5.5 China Facial Erythema Therapies Market Analysis 5.5.1 China Facial Erythema Therapies Production 5.5.2 China Facial Erythema Therapies Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Facial Erythema Therapies Import and Export 5.6 Japan Facial Erythema Therapies Market Analysis 5.6.1 Japan Facial Erythema Therapies Production 5.6.2 Japan Facial Erythema Therapies Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Facial Erythema Therapies Import and Export 5.7 Southeast Asia Facial Erythema Therapies Market Analysis 5.7.1 Southeast Asia Facial Erythema Therapies Production 5.7.2 Southeast Asia Facial Erythema Therapies Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Facial Erythema Therapies Import and Export 5.8 India Facial Erythema Therapies Market Analysis 5.8.1 India Facial Erythema Therapies Production 5.8.2 India Facial Erythema Therapies Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Facial Erythema Therapies Import and Export 6 Facial Erythema Therapies Segment Market Analysis (by Type) 6.1 Global Facial Erythema Therapies Production by Type 6.2 Global Facial Erythema Therapies Revenue by Type 6.3 Facial Erythema Therapies Price by Type 7 Facial Erythema Therapies Segment Market Analysis (by Application) 7.1 Global Facial Erythema Therapies Consumption by Application 7.2 Global Facial Erythema Therapies Consumption Market Share by Application (2014-2019) 8 Facial Erythema Therapies Major Manufacturers Analysis 8.1 Novartis 8.1.1 Novartis Facial Erythema Therapies Production Sites and Area Served 8.1.2 Novartis Product Introduction, Application and Specification 8.1.3 Novartis Facial Erythema Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Pfizer 8.2.1 Pfizer Facial Erythema Therapies Production Sites and Area Served 8.2.2 Pfizer Product Introduction, Application and Specification 8.2.3 Pfizer Facial Erythema Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Sanofi-Aventis 8.3.1 Sanofi-Aventis Facial Erythema Therapies Production Sites and Area Served 8.3.2 Sanofi-Aventis Product Introduction, Application and Specification 8.3.3 Sanofi-Aventis Facial Erythema Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Merck 8.4.1 Merck Facial Erythema Therapies Production Sites and Area Served 8.4.2 Merck Product Introduction, Application and Specification 8.4.3 Merck Facial Erythema Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Enzon Pharmaceuticals 8.5.1 Enzon Pharmaceuticals Facial Erythema Therapies Production Sites and Area Served 8.5.2 Enzon Pharmaceuticals Product Introduction, Application and Specification 8.5.3 Enzon Pharmaceuticals Facial Erythema Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Bayer 8.6.1 Bayer Facial Erythema Therapies Production Sites and Area Served 8.6.2 Bayer Product Introduction, Application and Specification 8.6.3 Bayer Facial Erythema Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Astellas Pharma 8.7.1 Astellas Pharma Facial Erythema Therapies Production Sites and Area Served 8.7.2 Astellas Pharma Product Introduction, Application and Specification 8.7.3 Astellas Pharma Facial Erythema Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 GSK 8.8.1 GSK Facial Erythema Therapies Production Sites and Area Served 8.8.2 GSK Product Introduction, Application and Specification 8.8.3 GSK Facial Erythema Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Abbott 8.9.1 Abbott Facial Erythema Therapies Production Sites and Area Served 8.9.2 Abbott Product Introduction, Application and Specification 8.9.3 Abbott Facial Erythema Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 9 Development Trend of Analysis of Facial Erythema Therapies Market 9.1 Global Facial Erythema Therapies Market Trend Analysis 9.1.1 Global Facial Erythema Therapies Market Size (Volume and Value) Forecast 2019-2025 9.2 Facial Erythema Therapies Regional Market Trend 9.2.1 North America Facial Erythema Therapies Forecast 2019-2025 9.2.2 Europe Facial Erythema Therapies Forecast 2019-2025 9.2.3 China Facial Erythema Therapies Forecast 2019-2025 9.2.4 Japan Facial Erythema Therapies Forecast 2019-2025 9.2.5 Southeast Asia Facial Erythema Therapies Forecast 2019-2025 9.2.6 India Facial Erythema Therapies Forecast 2019-2025 9.3 Facial Erythema Therapies Market Trend (Product Type) 9.4 Facial Erythema Therapies Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Facial Erythema Therapies Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Facial Erythema Therapies Table Global Facial Erythema Therapies Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Facial Erythema Therapies Production Market Share by Types in 2018 Figure Rx Product Picture Figure OTC Product Picture Table Global Facial Erythema Therapies Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Facial Erythema Therapies Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinic Figure Other Figure Global Facial Erythema Therapies Revenue (Million USD) (2014-2025) Figure Global Facial Erythema Therapies Production (K Units) (2014-2025) Figure North America Facial Erythema Therapies Market Size (Million USD) (2014-2025) Figure Europe Facial Erythema Therapies Market Size (Million USD) (2014-2025) Figure China Facial Erythema Therapies Market Size (Million USD) (2014-2025) Figure Japan Facial Erythema Therapies Market Size (Million USD) (2014-2025) Figure Southeast Asia Facial Erythema Therapies Market Size (Million USD) (2014-2025) Figure India Facial Erythema Therapies Market Size (Million USD) (2014-2025) Table Facial Erythema Therapies Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Facial Erythema Therapies in 2018 Figure Manufacturing Process Analysis of Facial Erythema Therapies Figure Industry Chain Structure of Facial Erythema Therapies Table Capacity and Commercial Production Date of Key Manufacturers Table Global Facial Erythema Therapies Manufacturing Plants Distribution Table Facial Erythema Therapies Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Facial Erythema Therapies Capacity (K Units) of Major Manufacturers (2014-2019) Table Facial Erythema Therapies Production (K Units) of Major Manufacturers (2014-2019) Table Facial Erythema Therapies Production Market Share of Major Manufacturers (2014-2019) Figure Facial Erythema Therapies Production Share by Manufacturers in 2018 Table Facial Erythema Therapies Revenue (Million US$) of Major Manufacturers (2014-2019) Table Facial Erythema Therapies Revenue Market Share of Major Manufacturers (2014-2019) Figure Facial Erythema Therapies Revenue Share by Manufacturers in 2018 Table Facial Erythema Therapies Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Facial Erythema Therapies Production by Regions 2014-2019 (K Units) Table Global Facial Erythema Therapies Production Market Share by Regions 2014-2019 Figure Global Facial Erythema Therapies Production Market Share by Regions in 2018 Table Global Facial Erythema Therapies Revenue by Regions 2014-2019 (Million USD) Table Global Facial Erythema Therapies Revenue Market Share by Regions 2014-2019 Figure Global Facial Erythema Therapies Revenue Market Share by Regions in 2018 Table Global Facial Erythema Therapies Consumption by Regions 2014-2019 (K Units) Table Global Facial Erythema Therapies Consumption Market Share by Regions 2014-2019 Figure North America Facial Erythema Therapies Production Growth Rate 2014-2019 (K Units) Figure North America Facial Erythema Therapies Revenue Growth Rate 2014-2019 (Million USD) Table North America Facial Erythema Therapies Production, Consumption Import and Export (K Units) Figure Europe Facial Erythema Therapies Production Growth Rate 2014-2019 (K Units) Figure Europe Facial Erythema Therapies Revenue Growth Rate 2014-2019 (Million USD) Table Europe Facial Erythema Therapies Production, Consumption Import and Export (K Units) Figure China Facial Erythema Therapies Production Growth Rate 2014-2019 (K Units) Figure China Facial Erythema Therapies Revenue Growth Rate 2014-2019 (Million USD) Table China Facial Erythema Therapies Production, Consumption Import and Export (K Units) Figure Japan Facial Erythema Therapies Production Growth Rate 2014-2019 (K Units) Figure Japan Facial Erythema Therapies Revenue Growth Rate 2014-2019 (Million USD) Table Japan Facial Erythema Therapies Production, Consumption Import and Export (K Units) Figure Southeast Asia Facial Erythema Therapies Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Facial Erythema Therapies Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Facial Erythema Therapies Production, Consumption Import and Export (K Units) Figure India Facial Erythema Therapies Production Growth Rate 2014-2019 (K Units) Figure India Facial Erythema Therapies Revenue Growth Rate 2014-2019 (Million USD) Table India Facial Erythema Therapies Production, Consumption Import and Export (K Units) Figure Global Consumption Facial Erythema Therapies Market Share by Application (2014-2019) Figure Global Value (Consumption) Facial Erythema Therapies Market Share by Application (2014-2019) Table Novartis Facial Erythema Therapies Production Sites and Area Served Table Novartis Facial Erythema Therapies Product Introduction, Application and Specification Table Novartis Facial Erythema Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Facial Erythema Therapies Production Growth Rate (2014-2019) Table Novartis Facial Erythema Therapies Production Market Share (2014-2019) Figure Novartis Facial Erythema Therapies Revenue Market Share (2014-2019) Table Novartis Facial Erythema Therapies Main Business and Markets Served Table Pfizer Facial Erythema Therapies Production Sites and Area Served Table Pfizer Facial Erythema Therapies Product Introduction, Application and Specification Table Pfizer Facial Erythema Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Facial Erythema Therapies Production Growth Rate (2014-2019) Table Pfizer Facial Erythema Therapies Production Market Share (2014-2019) Figure Pfizer Facial Erythema Therapies Revenue Market Share (2014-2019) Table Pfizer Facial Erythema Therapies Main Business and Markets Served Table Sanofi-Aventis Facial Erythema Therapies Production Sites and Area Served Table Sanofi-Aventis Facial Erythema Therapies Product Introduction, Application and Specification Table Sanofi-Aventis Facial Erythema Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi-Aventis Facial Erythema Therapies Production Growth Rate (2014-2019) Table Sanofi-Aventis Facial Erythema Therapies Production Market Share (2014-2019) Figure Sanofi-Aventis Facial Erythema Therapies Revenue Market Share (2014-2019) Table Sanofi-Aventis Facial Erythema Therapies Main Business and Markets Served Table Merck Facial Erythema Therapies Production Sites and Area Served Table Merck Facial Erythema Therapies Product Introduction, Application and Specification Table Merck Facial Erythema Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck Facial Erythema Therapies Production Growth Rate (2014-2019) Table Merck Facial Erythema Therapies Production Market Share (2014-2019) Figure Merck Facial Erythema Therapies Revenue Market Share (2014-2019) Table Merck Facial Erythema Therapies Main Business and Markets Served Table Enzon Pharmaceuticals Facial Erythema Therapies Production Sites and Area Served Table Enzon Pharmaceuticals Facial Erythema Therapies Product Introduction, Application and Specification Table Enzon Pharmaceuticals Facial Erythema Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Enzon Pharmaceuticals Facial Erythema Therapies Production Growth Rate (2014-2019) Table Enzon Pharmaceuticals Facial Erythema Therapies Production Market Share (2014-2019) Figure Enzon Pharmaceuticals Facial Erythema Therapies Revenue Market Share (2014-2019) Table Enzon Pharmaceuticals Facial Erythema Therapies Main Business and Markets Served Table Bayer Facial Erythema Therapies Production Sites and Area Served Table Bayer Facial Erythema Therapies Product Introduction, Application and Specification Table Bayer Facial Erythema Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Bayer Facial Erythema Therapies Production Growth Rate (2014-2019) Table Bayer Facial Erythema Therapies Production Market Share (2014-2019) Figure Bayer Facial Erythema Therapies Revenue Market Share (2014-2019) Table Bayer Facial Erythema Therapies Main Business and Markets Served Table Astellas Pharma Facial Erythema Therapies Production Sites and Area Served Table Astellas Pharma Facial Erythema Therapies Product Introduction, Application and Specification Table Astellas Pharma Facial Erythema Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Astellas Pharma Facial Erythema Therapies Production Growth Rate (2014-2019) Table Astellas Pharma Facial Erythema Therapies Production Market Share (2014-2019) Figure Astellas Pharma Facial Erythema Therapies Revenue Market Share (2014-2019) Table Astellas Pharma Facial Erythema Therapies Main Business and Markets Served Table GSK Facial Erythema Therapies Production Sites and Area Served Table GSK Facial Erythema Therapies Product Introduction, Application and Specification Table GSK Facial Erythema Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table GSK Facial Erythema Therapies Production Growth Rate (2014-2019) Table GSK Facial Erythema Therapies Production Market Share (2014-2019) Figure GSK Facial Erythema Therapies Revenue Market Share (2014-2019) Table GSK Facial Erythema Therapies Main Business and Markets Served Table Abbott Facial Erythema Therapies Production Sites and Area Served Table Abbott Facial Erythema Therapies Product Introduction, Application and Specification Table Abbott Facial Erythema Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Abbott Facial Erythema Therapies Production Growth Rate (2014-2019) Table Abbott Facial Erythema Therapies Production Market Share (2014-2019) Figure Abbott Facial Erythema Therapies Revenue Market Share (2014-2019) Table Abbott Facial Erythema Therapies Main Business and Markets Served Figure Global Facial Erythema Therapies Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Facial Erythema Therapies Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Facial Erythema Therapies Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Facial Erythema Therapies Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Facial Erythema Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Facial Erythema Therapies Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Facial Erythema Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Facial Erythema Therapies Production Growth Rate Forecast 2019-2025 (K Units) Figure China Facial Erythema Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Facial Erythema Therapies Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Facial Erythema Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Facial Erythema Therapies Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Facial Erythema Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Facial Erythema Therapies Production Growth Rate Forecast 2019-2025 (K Units) Figure India Facial Erythema Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Facial Erythema Therapies by Type (2019-2025) Table Global Consumption (K Units) of Facial Erythema Therapies by Application (2019-2025) Table Facial Erythema Therapies Distributors List Table Facial Erythema Therapies Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novartis Pfizer Sanofi-Aventis Merck Enzon Pharmaceuticals Bayer Astellas Pharma GSK Abbott